This is a prospective single-arm pilot study investigating the safety and feasibility of giving hyperthermic intravesical chemotherapy immediately following transurethral resection of bladder tumour.
Conditions: Bladder Cancer, Hyperthermia, Chemotherapy Effect
Eligibility Criteria
Inclusion Criteria
- years or above with informed consent
Exclusion Criteria
- ECOG performance status ≥2
- ASA 4 or above
- History of bleeding disorder
- Any use of anti-coagulants
- Pregnancy
Eligibility criteria are kept as the original English records from ClinicalTrials.gov; actual eligibility is determined by the research team's formal assessment and the informed consent form. Source: ClinicalTrials.gov, updated automatically every two weeks. Last synced: 2026年11月5日.